Our goal is to understand the developmental biology of pancreatic beta-cell origin and fate as a function of age. Limited beta-cell regeneration may play a fundamental role in type 2 diabetes mellitus (T2DM), especially in the elderly. beta-cell mass is reduced in T2DM patients, which may impair beta-cell function. In the past ss-cell mass was considered to be highly dynamic. But our studies suggest that beta-cell regeneration is restricted in maturity. We therefore hypothesize that the age-related decline in beta-cell regeneration contributes to diabetes pathogenesis. Whereas self-renewal is the primary mechanism of beta-cell growth in young mice, beta-cell neogenesis might also occur under some circumstances. Surprisingly, beta-cell mass continues to expand in aged mice, despite severely reduced ss-cell turnover rates. We therefore hypothesize that ss-cell neogenesis could contribute to beta-cell mass expansion in the elderly. Thus, the following aims: 1.) Determine the lifespan and cell of origin of pancreatic beta cells in healthy aged mice. We will quantify cell turnover rates of aged beta-cells, and define the origin of new beta- cells in healthy aging. 2.) Determine the lifespan and cell of origin of pancreatic beta-cells in pathological aging. We will quantify beta-cell mass expansion of aged mice in response to regenerative stimuli, injury (partial pancreatectomy, pancreatic ductal ligation, streptozotocin mediated beta-cell loss) or diabetes therapies (exendin- 4, sitagliptin). We will then define the cell of origin of new beta-cells in pathological aging, carrying out lineage tracing studies of ss-cells combined with regenerative stimuli. Finally, we will test the hypothesis that the """"""""replication refractory period"""""""" of beta-cell turnover limits cell cycle entry of aged beta cells. We will determine the number of cell divisions of beta-cells in aged mice in response to regenerative stimuli. In summary, these studies use innovative tools to precisely follow fate of aged beta-cells and their progenitors during regeneration.

Public Health Relevance

Improved understanding of the developmental biology of aged beta-cells is a critically important problem in diabetes research. The studies in this application will allow us to identify the cellular targets and regenerative potential of aged beta-cells, an indispensable knowledge gap obstructing beta-cell regeneration therapies for elderly T2DM patients.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-2 (M1))
Program Officer
Murthy, Mahadev
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Cox, Aaron R; Lam, Carol J; Bonnyman, Claire W et al. (2015) Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice. Diabetologia 58:1523-31
Shields, Emily J; Lam, Carol J; Cox, Aaron R et al. (2015) Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS One 10:e0129809
Sartori, Daniel J; Wilbur, Christopher J; Long, Simon Y et al. (2014) GATA factors promote ER integrity and *-cell survival and contribute to type 1 diabetes risk. Mol Endocrinol 28:28-39
Elahi, Dariush; Mirmira, Raghavendra G; Kushner, Jake A (2014) Editorial: in praise of scientific review officers. Mol Endocrinol 28:987-8
Rankin, Matthew M; Wilbur, Christopher J; Rak, Kimberly et al. (2013) β-Cells are not generated in pancreatic duct ligation-induced injury in adult mice. Diabetes 62:1634-45
Kushner, Jake A (2013) The role of aging upon β cell turnover. J Clin Invest 123:990-5
Kushner, Jake A (2012) Development. Esophageal stem cells, where art thou? Science 337:1051-2